Tejasav S. Sehrawat

TL;DR: A comprehensive review of the current literature on post-acute COVID-19, its pathophysiology and its organ-specific sequelae is provided in this paper, where the authors discuss relevant considerations for the multidisciplinary care of COPD survivors and propose a framework for the identification of those at high risk for COPD and their coordinated management through dedicated COPD clinics.

TL;DR: The extrapulmonary organ-specific pathophysiology, presentations and management considerations for patients with COVID-19 are reviewed to aid clinicians and scientists in recognizing and monitoring the spectrum of manifestations, and in developing research priorities and therapeutic strategies for all organ systems involved.

TL;DR: In studies of L SECs and knockout mice, mechanosensitive angiocrine signals released by LSECs are identified which promote PHTN by recruiting sinusoidal neutrophils and promoting formation of NETs and microthrombi.

TL;DR: This study aims to assess the safety and efficacy signals of F‐652 in patients with moderate and severe AH.

TL;DR: In mouse hepatocytes, activated IRE1A promotes transcription of serine palmitoyltransferase genes via XBP1, resulting in ceramide biosynthesis and release of EVs, and strategies to block this pathway might be developed to reduce liver inflammation in patients with NASH.